Visualizing early allograft rejection: an M1 macrophage-specific GLUT1 probe predicts TCMR onset in renal transplantation

M1-type macrophages are recruited in large numbers in the early stage of transplantation and play a key role in the progression of rejection. Glucose transporter-1 (GLUT1) is crucial for M1-type macrophages to exert pro-inflammatory effects. In the early stage of rejection, due to the high metabolic demand of M1-type macrophages, the expression of GLUT1 is significantly upregulated. These findings highlight the potential of GLUT1 as a predictive biomarker for guiding early and precise monitoring of rejection. In conclusion, this study provides an alternative method for early and non-invasive monitoring of allograft rejection.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-10-02
DOI
https://doi.org/10.3389/fimmu.2025.1670370
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Visualizing early allograft rejection: an M1 macrophage-specific GLUT1 probe predicts TCMR onset in renal transplantation

Fanchao Wei, Changhong Shi, Song Hong-tao, Ruochen Qi et al.
Frontiers in Immunology
Renal Transplantation Outcomes and Treatments
article

Visualizing early allograft rejection: an M1 macrophage-specific GLUT1 probe predicts TCMR onset in renal transplantation

Fanchao Wei, Changhong Shi, Song Hong-tao, Ruochen Qi, Lang Li, Shuaijun Ma, Weijun Qin, Dayuan Huang, Jingliang Zhang, Zhaoxiang Wang, Zhengxuan Li, Shichao Han, Yuxuan Du
article en

Abstract

M1-type macrophages are recruited in large numbers in the early stage of transplantation and play a key role in the progression of rejection. Glucose transporter-1 (GLUT1) is crucial for M1-type macrophages to exert pro-inflammatory effects. In the early stage of rejection, due to the high metabolic demand of M1-type macrophages, the expression of GLUT1 is significantly upregulated. These findings highlight the potential of GLUT1 as a predictive biomarker for guiding early and precise monitoring of rejection. In conclusion, this study provides an alternative method for early and non-invasive monitoring of allograft rejection.

Frontiers in ImmunologyVol. 16
Air Force Engineering University (CN), Xijing Hospital (CN)
Openalex Percentile: Top 57%
Renal Transplantation Outcomes and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.